Universal Ibogaine Inc
XTSX:IBO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
|
Universal Ibogaine Inc
XTSX:IBO
|
3.1m CAD |
Loading...
|
|
| CN |
|
Wenzhou Kangning Hospital Co Ltd
HKEX:2120
|
717.1m HKD |
Loading...
|
|
| CA |
|
Greenbrook TMS Inc
TSX:GTMS
|
28.6m CAD |
Loading...
|
|
| US |
|
Ethema Health Corp
OTC:GRST
|
3.1m USD |
Loading...
|
|
| US |
|
Tocca Life Holdings Inc
OTC:TLIF
|
474.6k USD |
Loading...
|
Market Distribution
Other Profitability Ratios
Universal Ibogaine Inc
Glance View
Universal Ibogaine, Inc. develops ibogaine based drug franchise to treat addiction and related mental health issues. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-21. The firm is focused on developing medicines and building a network of holistic recovery clinics for the treatment of addictions. The company treats addictions primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. Its focuses on developing ibogaine for the treatment of opioid use disorders. Ibogaine is a neuroactive compound, which is derived from various plants. Ibogaine helps to repair damaged brain tissues of the patients and helps them to recover and rebuild their lives.
